Research Article: Impact of ESPGHAN no-biopsy strategy on the outcome of celiac disease treatment in children
Abstract:
Aim: The European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) allows a no-biopsy diagnostic of celiac disease under certain conditions. We assessed the impact of the diagnostic algorithm on the patient's long-term outcome by comparing the serology-based diagnosed patients to biopsy-proven ones.
No summary available.